Cytotoxic action of Ganoderma lucidum on interleukin-3 dependent lymphoma DA-1 cells: Involvement of apoptosis proteins

Phytotherapy Research

Volumn 25, Issue 1, 2011, Pages 25-32

  Calviño, Eva ^a   Pajuelo, Lucía ^a   De Eribe Casas, Jon A Ochoa ^a   Manjõn, José Luis ^a   Tejedor, M Cristina ^a   Herráez, Angel ^a   Alonso, Manuel Díez ^b   Diez, José C ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

Bax; Bcl 2; Ganoderma lucidum (Curtis) P. Karst., Ganodermataceae Donk; lymphoma; p53

Indexed keywords

GANODERMA LUCIDUM EXTRACT; INTERLEUKIN 3; PROTEIN BAX; PROTEIN KINASE B; PROTEIN MDM2; PROTEIN P53; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; DRUG PURIFICATION; LYMPHOMA CELL; MOUSE; NONHUMAN; SOLVENT EXTRACTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CYTOTOXINS; DNA FRAGMENTATION; INTERLEUKIN-3; LYMPHOMA; MICE; PHOSPHORYLATION; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MDM2; REISHI; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

GANODERMA LUCIDUM; GANODERMATACEAE;

EID: 78650652993     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3202     Document Type: Article

References (45)

1. Allen RT, Cluck MW, Agrawal DK., 1998. Mechanisms controlling cellular suicide: role of Bcl-2 and caspases. Cell Mol Life Sci 54: 427-445.
2. Barak Y, Juven T, Haffner R, Oren M., 1993. Mdm2 expression is induced by wild type p53 activity. EMBO J 12: 461-468.
3. Cao QZ, Lin ZB., 2004. Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide. Acta Pharmacol Sin 25: 833-838.
4. Chang S-T, Miles P., 2004. Mushrooms: Cultivation, Nutritional Value, Medicinal Effect, and Environmental Impact. CRC Press: Boca Raton.
5. Chen J, Wu X, Lin J, Levine AJ., 1996. Mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol Cell Biol 16: 2445-2452.
6. Cheung WMW, Hui WS, Chu PWK, Chiu SW, Ip NY., 2000. Ganoderma extract activates MAP kinases and induces the neuronal differentiation of rat pheochromocytoma PC12 cells. FEBS Lett 486: 291-296.
7. Chiou SK, Rao L, White E., 1994. Bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol 14: 2556-2563.
8. Gottlieb E, Haffner R, von Ruden T, Wagner EF, Oren M., 1994. Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J 13: 1368-1374.
9. Gottlieb E, Lindner S, Oren M., 1996. Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells. Cell Growth Diff 7: 301-310.
10. Gottlieb E, Oren M., 1998. p53 facilitates pRb cleavage in IL-3-deprived cells: novel pro-apoptotic activity of p53. EMBO J 17: 3587-3596.
11. Hong KJ, Dunn DM, Shen CL, Pence BC., 2004. Effects of Ganoderma lucidum on apoptotic and anti-inflammatory function in HT-29 human colonic carcinoma cells. Phytother Res 18: 768-770.
12. Hu H, Ahn NS, Yang X, Lee YS, Kang KS., 2002. Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int J Cancer 102: 250-253.
13. Jiang J, Slivova V, Harvey K, Valachovicova T, Sliva D., 2004a. Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-kappaB signaling. Nutr Cancer 49: 209-216.
14. Jiang J, Slivova V, Valachovicova T, Harvey K, Sliva D., 2004b. Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3. Int J Oncol 24: 1093-1099.
15. Li CH, Chen PY, Chang UM, et al,. 2005. Ganoderic acid X, a lanostanoid triterpene, inhibits topoisomerases and induces apoptosis of cancer cells. Life Sci 77: 252-265.
16. Lin SB, Li CH, Lee SS, Kan LS., 2003. Triterpene-enriched extracts from. Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life Sci 72: 2381-2390.
17. Lin ZB., 2005. Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum. J Pharmacol Sci 99: 144-153.
18. Liu X, Yuan J-P, Chung Ch-K, Chen X-J., 2002. Antitumor activity of the sporoderm-broken germinating spores of Ganoderma lucidum. Cancer Lett 182: 155-161.
19. Lowe S, Bodis S, McClatchey A, et al,. 1994. p53 status and the efficacy of cancer therapy in vivo. Science 266: 807-810.
20. Lu QY, Jin YS, Zhang Q, et al,. 2004. Ganoderma lucidum extracts inhibit growth and induce actin polymerization in bladder cancer cells in vitro. Cancer Lett 216: 9-20.
21. Mayo MW, Baldwin AS., 2000. The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance. Biochim Biophys Acta 1470: M55-M62.
22. Merino JJ, Cordero-Campaña MI., 1998. Molecular bases of the programmed cell death process: implications of tumor suppressor protein p53 and other proteins in the control of cell cycle. Mechanisms of apoptotic action. Invest Clin 39: 323-358.
23. Messmer UK, Brüne B., 1997. Attenuation of p53 expression and Bax down-regulation during phorbol ester mediated inhibition of apoptosis. Br J Pharmacol 121: 625-634.
24. Min BS, Gao JJ, Nakamura N, Hattori M., 2000. Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem Pharm Bull 48: 1026-1033.
25. Miyashita T, Reed JC., 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299.
26. Mizushina Y, Hanashima L, Yamaguchi T, Takemura M, Sugawara F, Saneyoshi M., 1998. A mushroom fruiting body-inducing substance inhibits activities of replicative DNA polymerases. Biochem Biophys Res Commun 249: 17-22.
27. Müller CI, Kumagai T, O'Kelly J, Seeram NP, Heber D, Koeffler HP., 2006. Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. Leuk Res 30: 841-848.
28. Newcomb EW., 1995. P53 gene mutations in lymphoid diseases and their possible relevance to drug resistance. Leuk Lymphoma 17: 211-221.
29. Olmos G, Prieto A, Herráez A, Tejedor MC, Alvarez-Mon M, Diez JC., 2005a. Involvement of Bax, Bcl-2 and caspase -3 in hydroxyurea- or etoposide-induced apoptosis of mouse interleukin-3-dependent lymphoma cells. Anticancer Res 25: 999-1008.
30. Olmos G, Prieto A, Herráez A, Tejedor MC, Alvarez-Mon M, Diez JC., 2005b. Quantitation of apoptosis induction by etoposide or hydroxyurea in mouse interleukin 3-dependent lymphoma cells. In Vivo 19: 455-464.
31. Palacios C, Gutierrez del Arroyo A, Silva A, Collins MK., 2000. The role of p53 in death of IL-3-dependent cells in response to cytotoxic drugs. Oncogene 19: 3556-3559.
32. Raisova M, Hossini AM, Eberle J, et al,. 2001. Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. J Invest Dermatol 117: 333-340.
33. Shibata A, Nagaya T, Imai T, Funahashi H, Nakao A, Seo H., 2002. Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells. Breast Cancer Res Treat 73: 237-243.
34. Sliva D., 2004. Cellular and physiological effects of Ganoderma lucidum (Reishi). Mini Rev Med Chem 4: 873-879. (Pubitemid 39200074)
35. Sliva D, Labarrere C, Slivova V, Sedlak M, Lloyd Jr FP, Ho NW., 2002. Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem Biophys Res Commun 298: 603-612.
36. Sone Y, Okuda R, Wada N, Kishida E, Misaki A., 1985. Structures and antitumor activities of the polysaccharides isolated from fruiting body and the growing culture of mycelium of Ganoderma lucidum. Agric Biol Chem 49: 2641-2653.
37. Stanley G, Harvey K, Slivova V, Jiang J, Sliva D., 2005. Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells. Biochem Biophys Res Commun 330: 46-52.
38. Tang W, Liu JW, Zhao WM, Wei DZ, Zhong JJ., 2006. Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells. Life Sci 80: 205-211.
39. Towbin H, Staehelin T, Gordon J., 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354.
40. Trotter J., 2004. WinMDI (Windows Multiple Document Interface for Flow Cytometry), version 2.8. Available from
41. Wilasrusmee C, Kittur S, Siddiqui J, Bruch D, Wilasrumee S, Kittur DS., 2002. In vitro immunomodulatory effects of ten commonly used herbs on murine lymphocytes. J Altern Complement Med 8: 467-475.
42. Williamson EM., 2001. Synergy and other interactions in phytomedicines. Phytomedicine 8: 401-409.
43. Xie JT, Wang CZ, Wicks S, et al,. 2006. Ganoderma lucidum extract inhibits proliferation of SW 480 human colorectal cancer cells. Exp Oncol 28: 25-29.
44. Yeung WH, Lu QY, Zhang Q, Go VLW., 2004. Chemical and biochemical basis of the potential anti-tumor properties of Ganoderma lucidum. Curr Top Nutraceut Res 2: 67-77.
45. Zhao HB, Lin SQ, Liu JH, Lin ZB., 2004. Polysaccharide extract isolated from Ganoderma lucidum protects rat cerebral cortical neurons from hypoxia/reoxygenation injury. J Pharmacol Sci 95: 294-298